 |
 |
-------------------------------------------------------------------------- Guilford Reports Brain Cell Regeneration -------------------------------------------------------------------------- BALTIMORE, MD, Sep 24 (Reuters) - Guilford Pharmaceuticals Inc. said Tuesday that interim results from a continuing study of Parkinson's disease in a primate model showed that one of its agents can cause brain cells to regenerate. The company said that the FKBP-neuroimmunophilin small molecule neurotrophic agent, which it calls GPI-1046, can also improve behavioral measures in the primate model of the disease. The results are from an ongoing three-part, dose-escalation study of GPI-1046 in a Rhesus monkey MPTP model of Parkinson's disease. Copyright 1997 Reuters Limited. <http://www.reutershealth.com/news/docs/199709/19970924ddd.html> -------------------------------------------------------------------------- [log in to unmask]